LBC
Lawrence B. Cohen Portfolio holdings
AUM
$2.06M
1-Year Est. Return
34.47%
1 Year Est. Return
+34.47%
AUM
$148M
AUM Growth
-$7.95M
(-5.1%)
Holding
69
Top Buys
| 1 | +$2.98M | |
| 2 | +$2.67M | |
| 3 | +$2.12M | |
| 4 |
IQVIA
IQV
|
+$2.05M |
| 5 |
General Dynamics
GD
|
+$688K |
Top Sells
| 1 | +$2.86M | |
| 2 | +$2.3M | |
| 3 | +$1.5M | |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.49M |
| 5 |
CVS Health
CVS
|
+$1.36M |
Sector Composition
| 1 | Technology | 27.46% |
| 2 | Healthcare | 15.19% |
| 3 | Consumer Discretionary | 11.64% |
| 4 | Financials | 10.49% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Lennox International
LII
$19.3B
| $380K | 0.26% |
1,014
|
|
||
52
Alnylam Pharmaceuticals
ALNY
$62.1B
| $319K | 0.22% |
1,800
|
|
||
53
3M
MMM
$88.8B
| $316K | 0.21% |
+4,034
|
|
||
54
Vanguard Total International Stock ETF
VXUS
$107B
| $313K | 0.21% |
5,850
|
|
||
55
Tesla
TSLA
$1.47T
| $225K | 0.15% |
900
-231
|
|
||
56
Berkshire Hathaway Class B
BRK.B
$1.06T
| $222K | 0.15% |
635
-29
|
|
||
57
AbbVie
ABBV
$409B
| $204K | 0.14% |
+1,370
|
|
||
58
RenovoRx
RNXT
$43.6M
| $129K | 0.09% |
97,165
|
|
||
59
AC Immune
ACIU
$281M
| $36.6K | 0.02% |
12,850
|
|
||
60
Quince Therapeutics
QNCX
$97.8M
| $12.5K | 0.01% |
11,126
|
|
||
|
61
Bristol-Myers Squibb
BMY
$90.7B
| – | – |
-23,260
|
|
||
62
Church & Dwight Co
CHD
$21.4B
| – | – |
-2,105
|
|
||
|
63
CVS Health
CVS
$105B
| – | – |
-19,662
|
|
||
64
Hubbell
HUBB
$23.1B
| – | – |
-8,634
|
|
||
65
Intel
INTC
$181B
| – | – |
-39,081
|
|
||
66
SPDR S&P MidCap 400 ETF Trust
MDY
$24.1B
| – | – |
-420
|
|
||
67
Materials Select Sector SPDR Fund
XLB
$5.47B
| – | – |
-27,743
|
|
||
68
Utilities Select Sector SPDR Fund
XLU
$22.2B
| – | – |
-19,336
|
|
||
|
HLGN
69
DELISTED
Heliogen, Inc.
HLGN
| – | – |
-748
|
|